This inventor holds 2 USPTO granted patents. Top assignees: Beckman Coulter, Inc., Molecular Tool, Inc.. Active years: 1998-2009.
Company Filing History:
Years Active: 1998-2009
Title: Innovations of Stephen E Lincoln
Introduction
Stephen E Lincoln is an accomplished inventor based in Cockeysville, MD (US). He has made significant contributions to the field of genetics through his innovative patents. With a total of 2 patents, Lincoln's work focuses on automatic genotype determination, which has the potential to revolutionize genetic analysis.
Latest Patents
Lincoln's latest patents include methods and devices for automatic genotype determination. The first patent describes a process where genotypes of a subject can be determined by analyzing a biological sample. Measurements of the intensity of allele-specific signals are obtained and used to generate reaction values. These reaction values are then compared to probability distributions to obtain conditional probabilities of genotypes of interest. The genotype of the subject is determined based on these measures of conditional probabilities. The second patent outlines a device that determines the genotype at selected loci within genetic material obtained from a biological sample. This device forms one or more data sets and establishes a set of probability distributions that associate hypothetical reaction values with corresponding probabilities for each genotype of interest.
Career Highlights
Throughout his career, Lincoln has worked with notable companies such as Molecular Tool, Inc. and Beckman Coulter, Inc. His experience in these organizations has contributed to his expertise in genetic technologies and innovations.
Collaborations
Lincoln has collaborated with various professionals in his field, including his coworker Michael R Knapp. These collaborations have further enhanced his research and development efforts in genetic analysis.
Conclusion
Stephen E Lincoln is a notable inventor whose work in automatic genotype determination has significant implications for genetic research. His innovative patents and collaborations reflect his commitment to advancing the field of genetics.
